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Background: The aim of the present study was to explore serological biomarkers which predict the outcome of
tonsillectomy for chronic tonsillitis.
Methods: A case study in a University ENT department of 24 adult patients with chronic tonsillitis (CHT) in comparison
to 24 patients with acute peritonsillar abscess (PTA) was performed. Blood samples for clinical routine hematological
and serological parameters were assessed prior to surgery (T-1) and five days (T5) after tonsillectomy. Outcome
6 months later (T180) was documented using the Glasgow Benefit Inventory (GBI) and the Specific Benefits from
Tonsillectomy Inventory (SBTI). Correlation analyses between CHT and PTA group as well as between the different time
points within each group concerning the serological parameters and the outcome parameters were performed.
Results: At T-1, patients in the CHT group presented with significantly higher lymphocytes counts (relative and
absolute), basophils (relative and absolute) and eosinophils but less white-cells, monocytes, neutrophils (absolute and
relative), alpha-1, alpha-2, beta globulins, immunoglobulin and lower C-reactive protein and procalcitonin values than
patients in the PTA group (all p < 0.05, respectively). Within each group, different significant changes of the serum
parameters (often in opposite direction) were observed between T-1 and T5. SBTI scores at T-1 were significantly lower
in the CHT group. In contrast, most GBI scores at T180 were significantly higher in the CHT group. Between T-1 and
T180 the SBTI scores improved in three quarters of the CHT patients but only in three fifths of the PTA patients. Higher
eosinophil counts and immunoglobulin E levels at T-1 predicted higher GBI scores at T180 in the CHT group.
Conclusions: This pilot study showed a specific serological pattern for patients with chronic tonsillitis with a specific
pattern of changes after tonsillectomy. But there is no established role for biomarkers currently used in clinical practice
to predict the outcome of tonsillectomy for chronic tonsillitis.
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Chronic tonsillitis (CHT) is one of the most frequent
otolaryngologic diseases. The standard therapeutic ap-
proach is tonsillectomy [1]. The widely accepted criteria
for surgery are at least 3–7 episodes of tonsillitis per
year despite medical therapy, but these criteria have
been arrived arbitrarily and there is no international
consensus [2]. It has been criticized that these clinical* Correspondence: orlando.guntinas@med.uni-jena.de
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reproduction in any medium, provided the orcriteria are too superficial and subjective. For instance,
worsening or improvement over time is not assessed [3].
Furthermore, the severity of the systemic reaction that
might be beyond this chronic focal inflammation is not
specified yet and taken into account for decision making
for surgery. Nevertheless, even with limited criteria for
patient selection for tonsillectomy the rates of satisfac-
tion with the outcome following surgery are high [4-6].
Although a frequent illness, the literature on surgery for
recurrent tonsillitis is limited, especially on surgery in
adults [1]. In adults only one small randomized trial with
70 patients and several methodological limitations wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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streptococcal pharyngitis benefit from tonsillectomy in
comparison to watchful waiting at 90 days [7,8]. Any ad-
vantages of surgery must be balanced against disadvan-
tages. Although rare, tonsillectomy can be associated
with life threatening complications such as (major bleed-
ing or sepsis resulting in a mortality rate between one of
15,000-35,000 procedures [8,9].
Thus, the question arises whether other and objective
indicators in patients with CHT might meet the demand
to better select patients for tonsillectomy. Recently, an
index of tonsillitis was proposed including the factors
tonsillitis episodes, morbidity period, presence of scler-
otic signs like tonsillar sclerosis, scar tissue formation
and obstruction of tonsillar crypts, and assessment of
streptococcus pyogenes in cultures or by PCR [10]. Clin-
ical studies validating the effectiveness of this index to
predict the outcome is, however, lacking.
The palatine tonsil is a major part of Waldeyer’s ring
and part of the mucosal immune system. Even in adults
with involution of the organ the tonsil hosts important
amounts of immunoglobulin-producing cells [11]. The
effects of chronic tonsillitis or of tonsillectomy on this
regional immune system or the systemic immunoregula-
tory effects and their influence in the well-being of the
patients are not well described.
In a first approach to 1) characterize the systemic re-
sponse of adult patients with CHT, 2) to describe the ef-
fect of tonsillectomy on this systemic response, and 3) to
analyze if the systemic response can predict the outcome
of tonsillectomy for CHT, we analyzed in a clinical study
a large set of serologic markers prior to and after tonsil-
lectomy in relation to the clinical outcome 6 months
later using the Glasgow Benefit Inventory (GBI) and the
Specific Benefits from Tonsillectomy Inventory (SBTI).
As control group we have chosen adult patients with
acute peritonsillar abscess (PTA) planned for bilateral




A prospective clinical cohort study was performed at the
Department of Otorhinolaryngology, University Jena,
Germany. Institutional review board approval by the eth-
ics committe of the Jena University was obtained prior
to study initiation. Each patient entering the study
signed consent.
Subjects
Adult patients (18 to 80 years of age) with chronic ton-
sillitis (CHT) admitted for tonsillectomy were included.
Patients with unilateral peritonsillar abscess (PTA) and
indication for tonsillectomy served as controls. All PTApatients received a bilateral tonsillectomy a chaud, i.e.,
surgical removal of the tonsils during acute inflamma-
tion. This type of control group was chosen (and pre-
ferred to a control group of healthy patients) to control
the surgical procedure itself as a confounding factor on
serologic changes and the functional outcome after sur-
gery. Chronic tonsillitis was defined clinically as chronic
infection of the palatine tonsils on the basis of recurrent
tonsillitis normally without severe symptoms. Because of
this, the patient had to present a history of recurrent in-
take of antibiotics. The tonsils could have been atrophic
as well as hypertrophic. Recurrence implied more than
two distinct episodes in a 12-month period, and chron-
icity a period longer than three months. Peritonsillar ab-
scess was defined as a painful pus collection of infected
material in the area of and around the tonsils as compli-
cation of an acute severe tonsillitis. The pus collection
was confirmed by aspiration. Patients with other chronic
inflammatory diseases, coagulation disorders, or malig-
nant tumors were excluded. The study enrolment period
was from July to December 2009. Fifty-two patients (26
patients for the study group and for the control group,
respectively) fulfilled the inclusion criteria. Four patients
(2 patients for the study group and for the control
group, respectively) had to be excluded because of de-
cline of participation. The amount of episodes of tonsil-
litis with the last 12 months prior to admission was
documented for all patients.
All patients underwent a cold steel dissection of both
palatine tonsils. Hemostasis was achieved by bipolar co-
agulation. All patients received antibiotics perioperatively,
because perioperative antibiotic treatment reduces post-
operative pain [12]. At the day of surgery (T0), a biopsy of
one tonsil (in case of peritonsillar abscess of the affected
side) was taken for microbiological investigations. The
bacteriological culture was performed for standard bac-
teriological analysis. The tonsillectomy specimens were
forwarded for routine histopathological investigation.
Outcome assessment
Each patient completed the Specific Benefits from Ton-
sillectomy Inventory (SBTI), questions 1 to 6 the day be-
fore surgery (T-1) and all eight questions of the SBTI
180 days after surgery (T180). Furthermore, all patients
completed the Glasgow Benefit Inventory (GBI) at T180.
At T-1 the patients answered the questionnaires in the
hospital At T180 the patients received the question-
naires by regular mail and business reply envelope. The
GBI measures patient benefit and was developed espe-
cially for otolaryngological interventions [13]. In scoring
the GBI, the responses to all 18 questions were averaged
so that all questions have equal weight. In addition to
the combined total GBI scores for quality of life changes
after tonsillectomy, the GBI subscale scores for general
Table 1 Comparison of serologic parameters in patients
with chronic tonsillitis to patients with peritonsillar






Mean SD* Mean SD*
Antistreptolysin O titer (IU/mL) 151.38 164.42 207.24 299.22 0.941
Basophils (Differential count; %) 0.42 0.23 0.17 0.093 0.000
Basophils(Gpt/L) 0.04 0.027 0.03 0.025 0.023
Alpha-1 globulin (SPEP; %) 4.19 0.77 5.83 1.10 0.000
Alpha-2 globulin (SPEP; %) 9.46 1.46 12.06 1.55 0.000
Albumin (SPEP; %) 58.04 3.54 53.11 3.19 0.000
Beta Globulin (SPEP; %) 11.58 1.89 12.75 1.36 0.005
Gamma Globulin (SPEP; %) 16.73 1.84 16.03 2.82 0.435
C-reactive protein (mg/L) 3.68 6.30 99.06 61.63 0.000
Eosinophils (Differential
count; %).
2.14 1.83 0.51 0.62 0.000
Eosinophils (Gpt/L) 0.14 0.10 0.06 0.074 0.001
Red-cell count 4.68 0.36 4.80 0.43 0.389
Hemoglobin (mmol/l) 8.45 0.76 8.83 0.86 0.153
Hematocrit 0.41 0.03 0.42 0.04 0.259
Immunoglobulin A (g/L) 2.23 1.74 2.80 0.96 0.007
Immunoglobulin E (kU/L) 117.71 186.42 92.88 105.28 0.468
Immunoglobulin G (g/L) 12.69 2.04 12.18 2.63 0.302
Immunoglobulin M (g/L) 1.03 0.53 1.15 0.52 0.444
White-cell count 7.21 1.66 12.49 3.58 0.000
Lymphocytes (Differential
count; %)
31.99 11.70 14.90 7.23 0.000
Lymphocytes (Gpt/L) 2.22 0.72 1.73 0.61 0.009
Mean corpuscular
hemoglobin (fmol)
1.81 0.11 1.84 0.08 0.932
Mean corpuscular hemoglobin
concentration (mmol/l)
20.72 0.53 20.98 0.42 0.082
Mean corpuscular volume (fL) 87.34 4.54 87.73 3.17 0.758
Monocytes (Differential
count; %)
7.00 1.67 8.40 3.20 0.038
Monocytes (Gpt/L) 0.49 0.14 1.04 0.44 0.000
Neutrophils (Gpt/L) 4.30 1.68 9.70 3.44 0.000
Neutrophils (Differential
count; %)
58.46 12.67 76.02 8.66 0.000
Procalcitonin (ng/mL) 0.07 0.03 0.10 0.04 0.033
Red Blood Cell Distribution
Width (%)
13.28 1.05 13.27 0.76 0.684
Platelet count (Gpt/L) 290.79 48.49 280.74 79.03 0.587
Proteins, total (g/L) 77.83 6.10 78.01 5.35 0.401
*SD standard deviation, **p p value due to Mann–Whitney U test; significant
p values (<0.05) in bold; IU International Unit, Gpt/L 109 cells per liter, SPEP
Serum protein electrophoresis.
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lated. The SBTI is a modified version of the GBI to
measure specific symptom responses to tonsillitis and
tonsillectomy [5]. Typical symptoms accompanying
chronic tonsillitis were summarized under the scale
‘symptom change’ (questions 1–3). The ‘reduced use of
resources’ scale comprises items such as antibiotic use,
doctor visits, sick leaves (questions 4–6). These two
scales provide five possible choices: a lot more frequently,
more frequently, the same as before, less frequently, a lot
less frequently. The impact from tonsillectomy on general
health and quality of life (QOL) is assessed by the scale
‘general benefit’ (Questions 7 and 8). Choices of answers
per item were: extremely positive, positive, no change,
negative, extremely negative. The average scores from
both inventories (GBI and SBTI) were then transposed
onto a continual benefit scale ranging from −100 to +100.
A score of −100 indicates maximal negative benefit, a
score of 0 indicates no benefit at all, and a score of +100
indicates maximal positive benefit to the patient’s quality
of life.
Serology
Blood samples for routine hematological and serological
tests as well as for aerob and anaerob microbiological
culture analysis were taken at T-1 and five days after
surgery (T5).
Statistics
We used IBM SPSS Statistics 19.0.0 for statistical ana-
lyses. Data is presented as means ± standard deviation if
not otherwise indicated. Chi-square test and Mann–
Whitney U test for independent samples were performed
to analyze differences between the CHT group and the
control group of PTA patients at each time point
(Tables 1, 2 and 3). Within each group, in the CHT
and separately in the PTA group, the correlation of
serology parameters at T-1 with the functional out-
come at T180 was examined with via Pearson prod-
uct–moment correlations. In reference to the results
of previous studies [6], the four most important
functional outcome subscales (GBI social subscale;
GBI physical subscale; SBTI resources subscale; SBTI
benefit subscale) were selected for multiple comparisons
(Additional file 1: Table S1 and Additional file 2: Table S2).
The Bonferroni correction was used to adjust the P value
while performing multiple comparisons: As four outcome
subscales were examined, the level of significance was set
at p < 0.0125 (=0.05/4). The Wilcoxon test for dependent
samples was used to analyze differences between the time
points T-1 and T5 or T180 within each study group
(Additional file 3: Table S3). All tests (with exception
of the correlation analysis, see above) were performed
2-tailed and conducted at a p < 0.05 significance level.
Table 2 Comparison of serologic parameters in patients
with chronic tonsillitis to patients with peritonsillar






Mean SD* Mean SD*
Antistreptolysin O titer (IU/mL) 138.46 162.15 269.48 360.14 0.398
Basophils (Differential count; %) 0.37 0.16 0.33 0.14 0.572
Basophils(Gpt/L) 0.03 0.02 0.03 0.011 0.736
Alpha-1 globulin (SPEP; %) 5.47 0.70 5.52 0.73 0.897
Alpha-2 globulin (SPEP; %) 11.25 1.23 12.05 1.10 0.026
Albumin (SPEP; %) 55.64 2.96 53.21 2.73 0.005
Beta Globulin (SPEP; %) 11.89 1.97 12.13 1.21 0.192
Gamma Globulin (SPEP; %) 15.75 1.84 17.10 2.94 0.105
C-reactive protein (mg/L) 16.81 13.66 15.37 12.23 0.639
Eosinophils (Differential
count; %).
2.46 1.45 2.17 1.52 0.417
Eosinophils (Gpt/L) 0.17 0.11 0.17 0.10 0.751
Red-cell count 4.39 0.47 4.60 0.45 0.121
Hemoglobin (mmol/L) 7.90 0.90 8.41 0.89 0.088
Hematocrit 0.38 0.04 0.40 0.04 0.149
Immunoglobulin A (g/L) 2.20 1.71 2.83 0.92 0.004
Immunoglobulin E (kU/L) 140.06 217.78 87.36 102.88 0.803
Immunoglobulin G (g/L) 11.67 1.83 12.45 3.34 0.823
Immunoglobulin M (g/L) 0.89 0.45 1.24 0.48 0.005
White-cell count 7.26 1.70 7.85 1.98 0.318
Lymphocytes (Differential
count; %)
25.63 7.29 26.75 9.45 0.489
Lymphocytes (Gpt/l) 1.84 0.59 2.06 0.75 0.245
Mean corpuscular hemoglobin
(fmol)
1.80 0.11 1.83 0.08 0.733
Mean corpuscular hemoglobin
concentration (mmol/L)
20.63 0.65 20.97 0.45 0.014
Mean corpuscular volume (fL) 87.30 4.27 87.15 3.48 0.255
Monocytes (Differential
count; %)
7.51 2.54 7.51 1.99 0.751
Monocytes (Gpt/L) 0.54 0.02 0.59 0.21 0.360
Neutrophils (Gpt/L) 4.68 1.34 5.01 1.66 0.542
Neutrophils (Differential
count; %)
64.03 7.83 63.24 10.04 0.589
Procalcitonin (ng/mL) 0.06 0.03 0.07 0.02 0.065
Red Blood Cell Distribution
Width (%)
13.16 1.14 12.87 0.62 0.403
Platelet count (Gpt/L) 285.95 59.86 324.91 75.84 0.209
Proteins, total (g/l) 73.66 5.63 74.53 6.60 0.639
*SD standard deviation, **p p value due to Mann–Whitney U test; significant
p values (<0.05) in bold; IU International Unit, Gpt/L 109 cells per liter, SPEP
Serum protein electrophoresis.
Table 3 Results of the Glasgow Benefit Inventory (GBI)







Mean SD* Mean SD*
GBI total score (T180) 24.2 20.9 7.8 15.5 0.013
GBI subscores (T180)
General health 25.6 21.4 7.0 17.0 0.009
Social support 6.7 20.5 2.1 5.7 0.965
Physical functioning 45.2 42.2 16.7 32.2 0.013
SBTI (T-1)
Total score −3.0 37.0 52.7 39.0 <0.0001
Symptom score −0.8 32.7 47.0 44.7 <0.0001
Resources −5.3 46.7 68.3 37.4 <0.0001
SBTI (T180)
Total score 68.8 41.3 67.9 34.3 0.571
Symptom score 66.7 40.8 62.2 33.0 0.412
Resources 72.5 43.7 76.2 39.1 0.891
Benefit 61.9 32.2 40.6 31.5 0.059
SBTI (ΔT***)
Total score 74.12 68.77 22.44 57.47 0.030
Symptom score 67.50 63.63 20.24 58.90 0.049
Resources 81.58 76.95 23.08 59.14 0.024
Absolute number of
patients with changes
of SBTI score between

















*SD standard deviation; **p p value due to Mann–Whitney U test; significant
p values (<0.05) in bold; ***the scores at T108 were subtracted from the
values at T-1; ****the sample size N could be smaller than 24 as not all
patients answered the SBTI T180 or answered all questions.
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Twenty-four patients with chronic tonsillitis (CHT) and
twenty-four patients with peritonsillar abscess (PTA)
were included. The sex ratio was significantly different
in both groups (p = 0.006): The CHT group was domi-
nated by female patients (18 women, 6 men), and vice
versa the PTA group (6 women, 18 men). The patients
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(average: 29 years; range: 19–59 years) than in the PTA
group (average: 39 years; range: 20–70 years). The num-
ber of allergic patients was not different in the groups
(p > 0.05) No allergic patient had allergy symptoms be-
tween T-1 and T5. On average significantly more tonsil-
litis episodes within the last 12 months were reported in
the CHT group in comparison to the PTA group (CHT
group: average: 3.9; range: 3–15 versus PTA group: aver-
age 0.8; range: 0–3; p < 0.0001).
Histopatholology confirmed the diagnosis of chronic
tonsillitis or peritonsillar abscess, respectively, in all
cases. Blood cultures were negative in all but 2 asymp-
tomatic cases: In one patient of the CHT group Micro-
coccus lylae was observed once in a blood sample at T1
and in one patient of the PTA group Streptococcus
epidermidis once at T5. Microbiology of the tonsils re-
vealed mixed infections in most samples. No pathogens
were found in two patients in the CHT group and in one
patient of the PTA group. In the CHT group the domin-
ant pathogens (> 2 cases) were: Streptococcus viridans
(18 cases), Staphylococcus aureus (8 cases), Neisseria
spp. (7 cases), and Streptococcus pyogenes (3 cases). In
the PTA group the most important pathogens were:
Streptococcus viridans (14 cases), coagulase-negative
staphylococci (7 cases), Neisseria spp. (5 cases), and
Staphylococcus aureus (4 cases).
Blood test results at T-1 and T5 are presented in
Tables 1, 2 and Additional file 3: Table S3, respect-
ively. At T-1, patients in the CHT group presented
with significantly higher relative and absolute lymphocytes
counts than patients in the PTA group (p < 0.0001 and
p = 0.009, respectively). Moreover, CHT patients had
higher relative and absolute basophils and eosinophils
(p < 0.001 and p = 0.023), and higher albumin values (p <
0.0001). In contrast, patients with PTA had higher white-
cell numbers (p < 0.0001), more monocytes (p < 0.0001),
more neutrophils (absolute and relative; p < 0.0001 and
p < 0.0001), more alpha-1, alpha-2 and beta globulins
(p < 0.0001; p < 0.0001; P = 0.005), higher immuno-
globulin A values (p = 0.0007) and higher C-reactive pro-
tein (p < 0.0001) and procalcitonin values (p = 0.033). At
T5, fewer differences between the CHT and the PTA
group were observed. Only albumin remained higher in
the CHT group than in the PTA group (p = 0.005). In
the PTA group immunoglobulin A and immunoglobu-
lin M as well as the mean corpuscular hemoglobin
concentration were higher (p = 0.004, p = 0.005 and
p = 0.014, respectively).
Within each group, different changes of the serum pa-
rameters between T-1 and T5, and these changes often
in opposite direction, were observed (Additional file 3:
Table S3). There was a significant different shift in the
serum protein electrophoresis: Albumin and gammaglobulin relatively decreased and the other proteins of
the serum electrophoresis increased after surgery in the
CHT group whereas albumin and gamma globulin rela-
tively increased and the other proteins increased in the
PTA group. C-reactive protein increased in the CHT but
decreased in the PTA group. Procalcitonin decreased in
both groups, but more prominent in the PTA group.
The immunoglobulins A, G and M only decreased in the
CHT group. Looking on the differential count, there was
a shift from relatively decreasing lymphocytes to rela-
tively increasing neutrophils in the CHT group and vice
versa in the PTA group. In parallel, an absolute decrease
of lymphocytes and increase of neutrophils accompanied by
an absolute decrease of platelets in the CHT group and vice
versa in the PTA group was observed. Due to surgery and
concomitant blood loss, a significant decrease of all directly
related parameters (red cells, hemoglobin, hematocrit and
others) was seen in both groups.
At T-1 prior to surgery all Specific Benefits from Tonsil-
lectomy Inventory (SBTI) scores were significantly lower
in the CHT than in the PTA group (Table 3). At T180 the
return rate of the questionnaires was better in the CHT
group than in the PTA group: 21 of 24 patients (86%) an-
swered at T180 whereas only 15 of 24 patients (63%)
responded in the PTA group. No bias by the non-
responders was seen in the CHT group: age, gender, num-
ber of tonsillitis episodes, all SBTI scores at T-1 were not
different between responders and non-responders (all
p > 0.05). In contrast, the age of non-responders in the
PTA group was lower than of the responders (median:
30 years versus 44 years, p = 0.025). After surgery and
re-evaulation at T180 these differences disappeared.
This was mainly related to the significant increase of
all SBTI scores within the CHT group (all p < 0.002).
The SBTI scores did not significantly increase after
surgery in the PTA group (all p > 0.05). All Glasgow
Benefit Inventory (GBI) scores (with exception of the
social support score) at T180 were significantly higher
in the CHT group than in the PTA group. Three quar-
ters of the patients showed an improvement in the
SBTI scores after surgery in the CHT group, whereas
only about half of the patients in the PTA showed such
an improvement. Neither at T-1 nor at T180 most SBTI
scores and GBI scores were influenced by age or gender
of the patients (all p > 0.05). Only the SBTI resource
score at T180 was significantly higher in female than
in male patients in the CHT group (p = 0.022).
A few serology parameters at T-1 were significantly as-
sociated with the function outcome at T180 as assessed
by the GBI and SBTI questionnaires (Additional file 1:
Table S1 and Additional file 2: Table S2). In both the ex-
perimental and in the control group the influence of the
preoperative serology markers did not give a unique pat-
tern for GBI and SBTI scores half a year after surgery. In
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more eosinophils (r = 0.764; p <0.001) as well as absolute
more eosinophils (r = 0.642; p = 0.003) and more im-
munoglobulin E (r = 0.712; p < 0.001) were correlated to
a better GBI social score. Moreover, a preoperative lower
red cell counts was related to a significant higher GBI
physical score (r = −0.546; p = 0.011) six months after
tonsillectomy. A significant correlation between sero-
logic markers prior to surgery and the STBI outcome
parameters was not seen.
In the PTA group (Additional file 2: Table S2), there
was only one significant correlation between pre-surgical
serology and functional outcome six months later: A
lower initial platelet count was related to a higher STBI
resources subscale (r = −0.676; p = 0.011)
Discussion
Using retrospective studies it is thought that up to 90%
of adult patients with chronic tonsillitis profit from ton-
sillectomy [4]. Using the GBI and the SBTI the present
study shows significant benefits for tonsillectomy. This
is in accordance with other studies using these question-
naires [5,14]. But even using these standardized assess-
ments GBI and SBTI in a prospective study might
overestimate the efficacy because a bias by the surgery
itself cannot be ruled out. This surgical bias might could
have been especially high in the PTA group as the acute
disease phase is extremely painful and the relief by ton-
sillectomy accordingly high. Therefore, it was very im-
portant to set the endpoint of the present study in
sufficient distance to the surgery, i.e. 180 days later. The
GBI in total and most questions of the SBTI consider
the efficacy in a retrospective perspective. To overcome
this problem, we used a control group with another dis-
ease but same surgery. Furthermore, we asked the applic-
able questions of the SBTI prior and after tonsillectomy.
By this, we clearly revealed that about three quarters of
the patients with chronic tonsillitis profit from tonsillec-
tomy and this cannot be attributed to the surgery itself.
Otherwise, up to one quarter of patients seems not to
profit significantly. Due to ‘The Information System of the
Federal Health Monitoring’ about 70,000 tonsillectomies
were performed 2009 in adults in Germany (http://www.
gbe-bund.de/). Taken into account tonsillectomies for
other reasons, it could be assumed that tonsillectomy for
chronic tonsillitis was not effective in terms of functional
benefit in about 15,000 cases. For the USA, of course, a
higher number could be estimated. Actually, this high
number should force us to improve the selection criteria
for adult tonsillectomy. We should look beyond clinical
criteria. Apparently, clinical criteria are insufficient predic-
tors for a good functional outcome after tonsillectomy.
The present study has some methodological limita-
tions. The sample size was small. Anyhow, the effort wasalready large with several blood samples at definitive
time points and a long follow-up of 180 days. The sero-
logic markers and results of surgery-specific quality of
life assessments showed a high variability. Additionally,
as expected there was an imbalance in the primary func-
tional outcome: the group of satisfied patients was much
larger than the group of unsatisfied patients (relation
4:1). Despite of this, several robust statistical results have
been observed. Nevertheless, due to the small sample
sizes a multivariate analysis would not be meaningful
and hence was omitted. There is no consensus how to
determine the outcome of tonsillectomy. The only ran-
domized trial on the effectiveness of tonsillectomy com-
pared to watchful waiting for chronic tonsillitis has been
criticized for its short follow-up of six months because it
could not been ruled out that the effect of tonsillectomy
would not be reduced if the follow-up was longer [7,8].
Furthermore, to use the number of episodes of sore
throats as primary outcome criterion was criticized as
this criterion is difficult to define and to standardize. In
the present study an identical follow up period of six
months was used but the surgery-specific quality of life
assessments GBI and SBTI were applied to determine
the functional outcome. The GBI has been proven to be
a valid instrument to study changes of the health status
after otolaryngological surgery including tonsillectomy
[14]. Because the GBI-items are of a general nature to
address postoperative changes, items of SBTI were spe-
cifically designed to assess only the symptoms of chronic
tonsillitis [5]. Both scores seem to be much more sensi-
tive than to count episodes of sore throat or tonsillitis to
evaluate the impact of tonsillectomy. Nevertheless, due
to the non-specific (GBI) versus specific design for ton-
sillectomy (SBTI) and because of the different perspec-
tive on the surgical procedures (GBI: retrospective
versus SBTI: prospective), both scores are not directly
comparable [5]. This became obvious in a recent study
and can be confirmed by the present investigation [5].
The serologic investigations revealed several principal
results: First, the serologic profiles form patients with
CHT differ from patients with PTA before surgery (T-1)
and partly opposite changes of these profiles can be ob-
served quickly after surgery (T5). At a first glance, this
should be taken for granted as the first group of patients
is suffering from a chronic and gradual inflammatory
disease whereas the second group suffers from an acute
abscess formation due to the aggressiveness of a local
bacterial infection. This should explain significantly
higher values for parameters related to hemogram and
positive (e.g. c-reactive protein) as well as negative acute
phase reactant (e.g. albumin) indicating acute inflamma-
tion in the PTA group prior to surgery and their drop
down after surgery (much higher c-reactive protein,
higher procalcitonin, more white cells, shift to relative
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other white cell types). In addition, there is the signifi-
cant shift in the serum protein electrophoresis from rela-
tive more albumin in the CHT group to alpha-1 and
alpha-2 globulin in the PTA group. The explanation for
the shift might be that the alpha globulins include sev-
eral acute phase proteins indicating acute inflammation.
More interesting are the significant lower immunoglobu-
lin A (IgA) values in the CHT group. The tonsils are part
of the MALT system (Mucosal associated lymphoid tis-
sues). The MALT system as part of the secondary
lymphoid tissue is one of the first defense barriers
against microorganisms. T and B lymphocytes in the
tonsils are mainly secreting IgA [11]. Although decreas-
ing with age this production is still relative high in
healthy adults [11]. It is well known that chronic tonsil-
litis leads to a decrease of IgA by its destruction of the
functional tonsil [11]. Moreover, a secretory IgA defi-
ciency is observed in tonsillectomized subjects [15]. But
actually this observation is exclusively based on postop-
erative data not taking into account that the deficiency
might have been established, at least partly, already prior
to surgery as part of the chronic inflammation of the
tonsil. We speculate that a lower level of IgA might be
the expression of a more advanced destruction of the
tonsil by the chronic inflammation. For the next investi-
gations we plan to measure also the salivary IgA level.
This would give a further hint on a modulated immune
defense in patients with chronic tonsillitis.
Looking on potential prognostic markers for the predi-
cation of better functional outcome, only a few significant
correlations between serologic markers and functional
outcome was observed in the CT group but only for one
parameter in the PTA group. A consistent and easy to ex-
plain pattern of markers was not found. This might sup-
port the hypothesis that chronic tonsillitis as a matter of
fact has systemic effects which can be counteracted by
tonsillectomy. Interestingly, higher eosinophil cell levels
and a higher immunoglobulin E level (additionally, eosino-
phil levels and immunoglobulin E level were highly corre-
lated to each other, data not shown) were correlated to
better functional outcome. A correlation to the atopy sta-
tus of the patients was not evident, but the sample sizes
might be too small to detect such an association. There is
some controversy if there is correlation between atopy
and adenotonsillar hypertrophy in children and a localized
tonsillar allergic reaction is also discussed [16]. Anyhow,
up to the present no data on this question is available for
adults with chronic tonsillitis. It is well known that eosino-
phils are part of the chronic inflammatory process in the
tonsils [17]. Furthermore, eosinophils are highly activated
and responsive to different inflammatory stimuli in chil-
dren with chronic tonsillitis [18]. But so far eosinophils
were not considered as a potential serologic prognosticmarker for outcome after tonsillectomy. In agreement
with the present results, it has been shown also for chil-
dren with chronic tonsillitis that serum IgE concentrations
are changed by tonsillectomy [19]. To proof the hypoth-
esis that eosinophils and its related inflammatory media-
tors might play more important role in chronic tonsillitis
it is planned not only to repeat the study with a larger
sample size to confirm the findings but also to add a gen-
omic and proteomic expression analysis with focus on the
eosinophil granulocyte function.
Conclusions
This study revealed that patients with chronic tonsillitis
show specific patterns of serologic parameters. These pa-
rameters change immediately after tonsillectomy. The
patterns and changes are significantly different from pa-
tients with acute peritonsillar abscess. Nevertheless, due
to the present pilot study it appears that the preoperative
serologic biomarkers to not clearly predict the outcome of
tonsillectomy for chronic tonsillitis. We propose to extend
the research program by gene expression profiling of the
blood and tonsillar tissue of the patients.
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